Eli Lilly’s New GLP-1 Pill Posts Better-Than-Expected Results Eli Lilly, a renowned pharmaceutical company, has recently made waves in the medical world with its groundbreaking GLP-1 pill, orforglipron. This experimental drug has surpassed all expectations by delivering exceptional results, particularly in terms of weight loss. In a remarkable turn of events, the highest dose of […]
Novo Nordisk’s “Super Ozempic” Trial Disappoints Again
Novo Nordisk’s “Super Ozempic” Trial Disappoints Again Novo Nordisk, a pharmaceutical giant known for its groundbreaking diabetes treatments, recently faced a setback with its highly anticipated next-generation drug, CagriSema. The company’s shares took a hit after the release of disappointing trial results that revealed CagriSema failed to outperform its competitor, Eli Lilly’s Mounjaro. The pharmaceutical […]